Free Trial

PaxMedica (PXMD) Earnings Date, Estimates & Call Transcripts

PaxMedica logo
$0.12
0.00 (0.00%)
(As of 11/4/2024 ET)

PaxMedica Latest Earnings Summary

Latest Q2 2024
Earnings Date
Sep. 20Estimated
Actual EPS
(Sep. 20)
-$0.39 Missed By -$0.39

PaxMedica released Q2 2024 earnings on September 20, 2024, reporting an EPS of -$0.39. PaxMedica currently has a trailing EPS of $0.00

Get PaxMedica Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PaxMedica and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

PXMD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

PXMD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

PaxMedica Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.43-$0.43-$0.43
Q2 20241-$0.30-$0.30-$0.30
Q3 20241-$0.22-$0.22-$0.22
Q4 20241-$0.21-$0.21-$0.21
FY 20244($1.16)($1.16)($1.16)

PaxMedica Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
9/20/2024Q2 2024--$0.39 -$0.39-$0.39--
5/13/2024Q1 2024-$0.43-$0.50 -$0.07-$0.50--
11/15/2023Q3 2023--$5.20 -$5.20-$5.20--
8/9/2023Q2 2023--$4.08 -$4.08-$0.24--
5/15/2023Q1 2023--$5.10 -$5.10-$0.30--
3/29/2023Q4 2022--$10.03 -$10.03-$0.59--
11/15/2022Q3 2022--$14.79 -$14.79-$0.87--


This page (NASDAQ:PXMD) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners